Understanding Treatment Response With Naltrexone Among White Alcoholics
Condition(s):AlcoholismLast Updated:November 21, 2019Completed
Hide Studies Not Open or Pending
Condition(s):AlcoholismLast Updated:November 21, 2019Completed
Condition(s):Nondependent Opioid Abuse, EpisodicLast Updated:May 31, 2012Completed
Condition(s):Methamphetamine Use DisorderLast Updated:May 3, 2021Completed
Condition(s):Crohn’s DiseaseLast Updated:September 6, 2018Completed
Condition(s):ObesityLast Updated:June 20, 2017Completed
Condition(s):Interstitial Cystitis; Painful Bladder Syndrome; Bladder Pain Syndrome; Low Dose Naltrexone; Low-dose Naltrexone; NaltrexoneLast Updated:April 28, 2023Completed
Condition(s):Methamphetamine-dependence; Methamphetamine AbuseLast Updated:January 31, 2024Not yet recruiting
Condition(s):Liver CirrhosisLast Updated:March 28, 2023Completed
Condition(s):Alcohol Use Disorder; Alcoholism; Alcohol AddictionLast Updated:March 31, 2023Recruiting
Condition(s):Opioid-use DisorderLast Updated:March 2, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.